CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
基本信息
- 批准号:6647745
- 负责人:
- 金额:$ 17.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:Drosophilidae carcinogenesis disease /disorder model gene expression gene mutation human subject laboratory mouse loss of heterozygosity neoplastic growth neoplastic transformation neuromuscular junction northern blottings patient oriented research polymerase chain reaction protein protein interaction protein structure function tuberous sclerosis tumor suppressor proteins
项目摘要
DESCRIPTION (provided by applicant): Tuberous sclerosis complex is multisystem
disorder characterized by the widespread development of growths known as
hamartomas in many tissues and organs, particularly within the brain, eyes,
skin, kidneys, heart, lungs and skeleton. The most severely affected system is
the central nervous system with the occurrence in affected individuals of
seizures (80-90 percent), mental retardation (50-60 percent), and autism (up to
50 percent). TSC is inherited as an autosomal dominant disorder, but
approximately two-thirds of affected patients are sporadic due to new germline
mutations. Genetic linkage studies have shown locus heterogeneity for the
disease, with at least two TSC determining genes on chromosomes 9 and 16 which
have been termed TSC1 and TSC2 respectively. The TSC1 gene encodes a novel
protein, hamartin that contains a single transmembrane domain and a large
cytoplasmic tail with a coiled-coil domain. The TSC2 gene encodes a novel
protein tuberin that contains a region of homology to the GTPase activating
protein rap1GAP. We have performed a comprehensive mutational analysis of the
TSC1 and TSC2 genes and noted that TSC1 mutations are significantly
underrepresented in sporadic patients. However, the occurrence of the second
somatic mutation in TSC lesions, particularly brain lesions is not clear. In
order to understand whether this is due to cellular pleomorphism, or if
haploinsufficiency of tuberin/hamartin is enough to promote tumor genesis, we
will perform genetic analysis on laser capture microdissected lesions. We have
identified a novel protein associated with Myc named Pam as an interacting
protein for tuberin. Mutations in both the Drosophila (hiw) and C. elegans
(rpm-1) homologs of Pam show synaptic overgrowth. Our hypothesis that Pam is an
essential component of the tuberin-hamartin complex, particularly in the CNS
where these proteins may have a critical role in cortical neuron function will
be examined. The domain of Pam that interacts with tuberin reveals 90 percent
similarity with the fly homolog HIW. The possible physical and genetic
interaction between the Drosophila TSC2 product Gigas and HIW will be examined.
Thus the studies aimed at defining the role of tuberin-hamartin in the
mammalian CNS will be further strengthened by the Drosophila model system where
genetic manipulations are possible. The information obtained here will
elucidate the physiological functions of these tumor suppressors, which will
aid in designing better therapies.
描述(由申请人提供):结节硬化症综合体是多系统
疾病以广泛发展的增长为特征
许多组织和器官中的Hamartomas,特别是在大脑中,眼睛,
皮肤,肾脏,心脏,肺部和骨骼。受影响最严重的系统是
中枢神经系统发生在受影响的个体中
癫痫发作(80-90%),智力低下(50-60%)和自闭症(最多可
50%)。 TSC遗传为常染色体显性疾病,但
大约三分之二的受影响患者由于新的种系而零星
突变。遗传联系研究表明基因座的异质性
疾病,至少有两个TSC确定染色体9和16上的基因
分别称为TSC1和TSC2。 TSC1基因编码小说
蛋白质,含有单个跨膜结构域和大型的Hamartin
具有盘绕螺旋域的细胞质尾巴。 TSC2基因编码小说
蛋白结核素包含与GTPase激活的同源性区域
蛋白质RAP1GAP。我们已经对
TSC1和TSC2基因,并指出TSC1突变显着
零星患者的代表性不足。但是,第二个发生
TSC病变,尤其是脑病变中的体细胞突变尚不清楚。在
为了了解这是否是由于细胞多态性的,还是
Tuberin/hamartin的单倍不足足以促进肿瘤起源,我们
将对激光捕获显微解剖病变进行遗传分析。我们有
确定了一种与MYC相关的新型蛋白质,称为PAM是一种相互作用
结核素的蛋白质。果蝇(HIW)和秀丽隐杆线虫的突变
(RPM-1)PAM的同源物显示突触过度生长。我们假设Pam是
结核素 - 哈马丁蛋白复合物的必要成分,尤其是在中枢神经系统中
这些蛋白质可能在皮质神经元功能中起关键作用的地方
被检查。与Tuberin相互作用的PAM领域显示90%
与Fly同源性HIW相似。可能的身体和遗传
将检查果蝇TSC2产品GIGAS和HIW之间的相互作用。
因此,研究旨在定义Tuberin-Hamartin在
果蝇模型系统将进一步加强哺乳动物的CNS
遗传操作是可能的。这里获得的信息将
阐明这些肿瘤抑制剂的生理功能,这将
有助于设计更好的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIJAYA RAMESH其他文献
VIJAYA RAMESH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIJAYA RAMESH', 18)}}的其他基金
NF2-associated meningiomas: From omics discovery to targeted therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10408180 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
NF2-Associated Meningiomas: From Omics Discovery to Targeted Therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10640996 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
NF2-associated meningiomas: From omics discovery to targeted therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10249966 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
Genes that deregulate mTOR signaling as candidates for autism spectrum disorders
解除 mTOR 信号传导的基因作为自闭症谱系障碍的候选基因
- 批准号:
7488759 - 财政年份:2007
- 资助金额:
$ 17.3万 - 项目类别:
Genes that deregulate mTOR signaling as candidates for autism spectrum disorders
解除 mTOR 信号传导的基因作为自闭症谱系障碍的候选基因
- 批准号:
7304882 - 财政年份:2007
- 资助金额:
$ 17.3万 - 项目类别:
2006 NF Consortium for NF1, NF2 and Schwannomatosis
2006 NF1、NF2 和神经鞘瘤病联盟
- 批准号:
7162767 - 财政年份:2006
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6931449 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别:
相似国自然基金
P2Y6受体在多发性骨髓瘤中的致癌作用及机制研究
- 批准号:82360043
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
致癌性人类乳头瘤病毒的起源和进化适应:评估人类和非人类灵长类动物乳头瘤病毒E6和E7致癌基因与宿主蛋白质组的相互作用
- 批准号:82372256
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新tsRNA分子m7G-3′tiRNA LysTTT介导化学致癌作用及其调控机制
- 批准号:82272995
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
RNA的m6A甲基化修饰在第3型髓母细胞瘤中的致癌功能及作用机制
- 批准号:82272936
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
PCBP1在HTLV-1感染诱导炎症和致癌过程中的调控作用及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of KSR in tumorigenesis and the radiation response
KSR 在肿瘤发生和放射反应中的作用
- 批准号:
6556262 - 财政年份:2003
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6931449 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6360325 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6529734 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6790531 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别: